Taiwanese Pharmaceuticals & Biotech High And Sustainable

Results

1 new

Companies in a sound financial shape with a dividend yield of more than 5%.

5 companies

TSH Biopharm

Market Cap: NT$1.9b

Develops and markets pharmaceutical products in Taiwan.

8432

NT$50.10

-1.6%

5.7%

Bioray Biotech

Market Cap: NT$575.4m

Engages in the research, development, production, and sells health foods, immune cell products, and precision testing services in Taiwan.

7561

NT$17.75

2.6%

-30.4%

Allied Biotech

Market Cap: NT$2.4b

Engages in the manufacture and sale of carotenoids worldwide.

1780

NT$25.00

6.6%

43.3%

TTY Biopharm

Market Cap: NT$19.1b

Engages in the development and sale of pharmaceutical and chemical drugs in Taiwan, the United States, and internationally.

4105

NT$79.20

2.7%

4.2%

SYN-TECH Chem. & Pharm

Market Cap: NT$3.3b

Manufactures and sells active pharmaceutical ingredients (APIs) in Taiwan, Asia, Europe, the Americas, and internationally.

1777

NT$73.80

-1.2%

-1.3%